A consent-aware screening funnel for studies where vascular cognition matters.

VascuMind helps identify, educate, baseline, and route people with vascular cognitive concerns before a sponsor spends deeply on downstream screening.

Research teams need better-fit candidates before expensive screening steps.

High screen-fail waste

Sponsors can spend heavily on biomarker confirmation before cognitive and vascular fit are clear.

Weak vascular differentiation

Many recruitment funnels do not separate ischemic-pattern, mixed, and non-vascular cognitive concerns early enough.

Poor consumer trust

Listing sites rarely create the plain-language confidence families need before they opt into research follow-up.

Consumer-grade front door. Vascular differentiation. Structured memory baseline. Consent-aware routing.

Earlier signal:
Find subtle cognitive impairment and vascular-risk context before late-stage disease.
Better fit:
Route ischemic-pattern and mixed impairment into better-aligned trial pathways.
Operating leverage:
Use one funnel for recruitment, baseline characterization, and repeat testing.

Flexible, value-aligned licensing tailored to study scope.

We structure licensing around study complexity, volume, and the level of implementation support needed. Specific pricing is discussed deal-by-deal after understanding your indication, sites, cohort size, and analytics requirements. Our benchmark: parity or premium to legacy cognitive tools when paired with vascular differentiation, ischemic-pattern fit, and campaign analytics.

Pilot

Custom pricing
Per-test pricing available

Single-study feasibility, one indication, defined site cohort

Standard

Custom pricing
Per-test pricing available

Active trial program with recruitment, screening, and monitoring workflow

Enterprise

Custom pricing
Custom

Multi-study, multi-region, or trial-network deployment

Why custom pricing?

  • Study scope varies: single indication vs. multi-study programs, regional vs. global
  • Implementation depth: self-serve configuration vs. full managed deployment
  • Analytics needs: basic conversion tracking vs. source-level cohort analytics
  • Volume commitments: pilot feasibility vs. guaranteed enrollment targets
  • All discussions include: implementation timeline, support SLA, and renewal terms
Memory signal summaryEducational only
Free checkVascular clues
Next stepMemory baseline
  • Stroke/TIA history questions
  • Blood-flow and vascular risk prompts
  • Clinician conversation checklist

Implementation workflow

  1. Define indication, inclusion/exclusion logic, countries, sites, participant volume, and consent requirements.
  2. Configure a condition-specific landing page, ischemic pattern check, memory baseline handoff, and research-interest form.
  3. Launch source-tracked campaigns and monitor conversion by message, site, audience, and score band.
  4. Use structured exports and operating reviews to refine recruitment, prequalification, and follow-up.

Compliance posture

  • Educational and trial-screening positioning, not consumer diagnosis.
  • Clinical validation claims must be sourced and reviewed before sponsor materials.
  • Consent, privacy, site requirements, and country-specific rules must be defined before deployment.
  • No identifiable consumer data is shared with sponsors or CROs without additional explicit consent.

Give sponsors a consumer-grade trial-readiness engine.

The DTC funnel creates awareness. The CRO license monetizes validated demand where vascular cognition matters most.

Preview Licensing One-Pager

Request CRO licensing packet

MCI Screen Disclaimer

The MCI Screen referenced by VascuMind is a cognitive screening, benchmarking, and tracking tool sourced from MCI Screen / EMBIC materials. It does not diagnose vascular dementia or any other medical condition and is not a substitute for clinical evaluation. Results should be discussed with a qualified healthcare provider.

These products are dietary supplements and are not intended to diagnose, treat, cure, or prevent vascular dementia, Alzheimer’s disease, MCI, stroke, or any other disease. Always consult your healthcare professional before use.
VascuMind® content is for educational purposes only and does not constitute medical advice or clinical guidance. Sudden neurologic symptoms require immediate emergency care (call 911). Supplement pages use structure/function wellness language, affiliate disclosure, and the required FDA dietary-supplement notice. Full compliance page: /compliance.